| Potential drugs used in the antibody–drug conjugate (ADC) architecture for cancer therapy S Yaghoubi, MH Karimi, M Lotfinia, T Gharibi, M Mahi‐Birjand, E Kavi, ... Journal of cellular physiology 235 (1), 31-64, 2020 | 144 | 2020 |
| Protective effects of pharmacological agents against aminoglycoside-induced nephrotoxicity: A systematic review M Mahi-Birjand, S Yaghoubi, M Abdollahpour-Alitappeh, Z Keshtkaran, ... Expert Opinion on Drug Safety 19 (2), 167-186, 2020 | 61 | 2020 |
| How hypoxia regulate exosomes in ischemic diseases and cancer microenvironment? S Yaghoubi, H Najminejad, M Dabaghian, MH Karimi, ... IUBMB life 72 (7), 1286-1305, 2020 | 40 | 2020 |
| Optimizing compliance with surgical antimicrobial prophylaxis guidelines in patients undergoing gastrointestinal surgery at a referral teaching hospital in southern Iran … L Mahmoudi, M Ghouchani, M Mahi-Birjand, A Bananzadeh, A Akbari Infection and drug resistance, 2437-2444, 2019 | 30 | 2019 |
| Ceftriaxone-associated nephrolithiasis and gallstone in adults G Azarkar, MM Birjand, A Ehsanbakhsh, B Bijari, MR Abedini, M Ziaee Drug, healthcare and patient safety, 103-108, 2018 | 25 | 2018 |
| Protective effects of silymarin on gentamicin-induced nephrotoxicity in infectious patients: a randomized double blinded placebo-controlled clinical trial M Mahi-Birjand, I Karimzadeh, A Zarban, M Abdollahpour-Alitappeh, ... Pharmaceutical Sciences 26 (3), 287-295, 2020 | 11 | 2020 |
| Key regulatory miRNAs and their interplay with mechanosensing and mechanotransduction signaling pathways in breast cancer progression H Najminejad, B Farhadihosseinabadi, M Dabaghian, A Dezhkam, ... Molecular Cancer Research 18 (8), 1113-1128, 2020 | 11 | 2020 |
| Evaluation of vancomycin therapy in the adult ICUs of a teaching hospital in southern Iran A Vazin, M Mahi Birjand, M Darake Drug, Healthcare and Patient Safety, 21-26, 2018 | 9 | 2018 |
| Investigating the sequential patterns of methamphetamine use initiation in Iran EM Sarani, J Ahmadi, B Oji, M Mahi-Birjand, N Bagheri, A Bazrafshan, ... Substance Abuse Treatment, Prevention, and Policy 15, 1-10, 2020 | 8 | 2020 |
| Evaluation of vancomycin use in university-affiliated hospitals in Southern Khorasan Province (East Iran) based on HICPAC guidelines M Mahi-Birjand, M Ziaee, B Bijari, R Khalvati, MR Abedini, ... Drug, Healthcare and Patient Safety, 29-35, 2019 | 7 | 2019 |
| Performance of drug and poison information center within a Referral University hospital in southwest of Iran I Karimzadeh, A Vazin, N Talebnia, N Hatami-Mazinani, M Mahi-Birjand Journal of Pharmaceutical Care, 49-55, 2017 | 6 | 2017 |
| Compliance with Antibiotics Prophylaxis Guideline in Surgical Patients in ICUs of a Teaching Referral Hospital A Vazin, N Hatami-Mazinani, E Alemzadeh, F Dehghani, M Mahi-Birjand Health services insights 15, 11786329221136437, 2022 | 3 | 2022 |
| Assessing the performance of community pharmacies in Iran by measuring responsiveness to non-medical needs: An application of WHO responsiveness framework S Afifi, AHA Bahmani, L Zarei, M Mahi-Birjand, M Hoorang, M Zare, ... Journal of research in pharmacy practice 10 (2), 59-64, 2021 | 3 | 2021 |
| Comparison of intravenous sodium bicarbonate and sodium chloride combination versus intravenous sodium chloride hydration alone in reducing amphotericin B nephrotoxicity: a … I Karimzadeh, A Sepehr-Sobhani, MJ Khoshnoud, MM Sagheb, R Vejdani, ... Research in Pharmaceutical Sciences 15 (6), 583-591, 2020 | 3 | 2020 |
| Aminoglycosides: Single-or Multiple-daily Dosing? An Updated Qualitative Systematic Review of Randomized Trials on Toxicity and Efficacy I Karimzadeh, M Abdollahpour-Alitappeh, S Ghaffari, M Mahi-Birjand, ... Current Molecular Medicine, 2024 | 1 | 2024 |
| Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran L Zarei, N Moradi, F Peiravian, N Hatami-Mazinani, M Mahi-Birjand, ... International Journal for Equity in Health 21 (1), 188, 2022 | 1 | 2022 |
| Investigation of SEN virus prevalence in hemophilia patients D Javanmard, M Mahi-Birjand, E Alemzadeh, M Mohammadi, M Ziaee New Microbes and New Infections 62, 101470, 2024 | | 2024 |
| Exploring the Efficacy of Convalescent Plasma Therapy in COVID-19 Patients: A Clinical Trial Study M Mahi-Birjand, M Ziaee, E Alemzadeh, A Barkhordari, Z Azarkar, ... Coronaviruses, 2024 | | 2024 |
| Comparison between Management and Pharmacotherapy of COVID-19 in Iran and Switzerland: Management and Pharmacotherapy of COVID-19 in Iran and Switzerland P Peymani, S Bazdar, L Zarei, M Hoorang, N Hatami-Mazinani, ... Novelty in Biomedicine 10 (4), 219-225, 2022 | | 2022 |
